Manufacturers Life Insurance Company, The Relay Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 215,547 shares of RLAY stock, worth $896,675. This represents 0.0% of its overall portfolio holdings.

Number of Shares

215,547

Previous 215,588 0.02%

Holding current value

$896,675

Previous $1.41 Million 8.61%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$6.23 - $9.51 $255 - $389	-41 Reduced 0.02%	215,547 $1.53 Million
Q2 2024 Aug 14, 2024	SELL	$5.9 - $8.02 $115,628 - $157,175	-19,598 Reduced 8.33%	215,588 $1.41 Million
Q1 2024 May 14, 2024	SELL	$7.5 - $12.07 $29,025 - $46,710	-3,870 Reduced 1.62%	235,186 $1.95 Million
Q4 2023 Feb 13, 2024	SELL	$6.01 - $11.48 $6,250 - $11,939	-1,040 Reduced 0.43%	239,056 $2.63 Million
Q3 2023 Nov 15, 2023	BUY	$8.24 - $12.97 $284,568 - $447,918	34,535 Added 16.8%	240,096 $2.02 Million
Q2 2023 Aug 11, 2023	BUY	$9.99 - $18.27 $991,287 - $1.81 Million	99,228 Added 93.32%	205,561 $2.58 Million
Q1 2023 May 15, 2023	BUY	$15.0 - $22.76 $927,330 - $1.41 Million	61,822 Added 58.14%	168,155 $2.77 Million
Q4 2022 Aug 11, 2023	BUY	$14.16 - $24.02 $45,142 - $76,575	3,188 Added 3.09%	106,333 $1.59 Million
Q4 2022 Feb 13, 2023	BUY	$14.16 - $24.02 $45,142 - $76,575	3,188 Added 3.09%	106,333 $1.59 Million
Q3 2022 Aug 11, 2023	BUY	$18.07 - $31.37 $126,074 - $218,868	6,977 Added 7.26%	103,145 $2.31 Million
Q3 2022 Nov 03, 2022	BUY	$18.07 - $31.37 $126,074 - $218,868	6,977 Added 7.26%	103,145 $2.36 Million
Q2 2022 Aug 11, 2023	BUY	$13.31 - $34.88 $101,235 - $265,297	7,606 Added 8.59%	96,168 $1.61 Million
Q2 2022 Aug 15, 2022	BUY	$13.31 - $34.88 $101,235 - $265,297	7,606 Added 8.59%	96,168 $1.61 Million
Q1 2022 Aug 11, 2023	SELL	$20.26 - $32.36 $1.61 Million - $2.58 Million	-79,593 Reduced 47.33%	88,562 $2.65 Million
Q1 2022 May 20, 2022	BUY	$20.26 - $32.36 $1.08 Million - $1.73 Million	53,376 Added 151.7%	88,562 $2.69 Million
Q4 2021 Feb 16, 2022	BUY	$26.0 - $37.03 $103,792 - $147,823	3,992 Added 12.8%	35,186 $1.1 Million
Q3 2021 Nov 12, 2021	SELL	$29.75 - $37.99 $58,161 - $74,270	-1,955 Reduced 5.9%	31,194 $984,000
Q2 2021 Aug 12, 2021	BUY	$27.5 - $38.19 $193,050 - $268,093	7,020 Added 26.87%	33,149 $1.21 Million
Q1 2021 May 03, 2021	BUY	$32.52 - $61.53 $206,339 - $390,407	6,345 Added 32.07%	26,129 $903,000
Q4 2020 Feb 12, 2021	BUY	$35.51 - $54.03 $77,660 - $118,163	2,187 Added 12.43%	19,784 $822,000
Q3 2020 Nov 09, 2020	BUY	$32.81 - $45.1 $577,357 - $793,624	17,597 New	17,597 $749,000

Others Institutions Holding RLAY

# of Institutions

204

Shares Held

156M

Call Options Held

207K

Put Options Held

40K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $500M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Relay Therapeutics, Inc. Transaction History